Related Experiment Video
Updated: Sep 17, 2025

11:56
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
12.6K
Coordination Polymer Carrying Antimicrobial Peptide for Enhanced Anti-Infective Therapy
Madiha Saqlain1, Hafiz Muhammad Zohaib1, Dilawar Akram2
1School of Chemistry and Chemical Engineering, Key Laboratory of Cluster Science of Ministry of Education, Beijing Institute of Technology, Beijing, 100081, P. R. China.
Chembiochem : a European Journal of Chemical Biology
|June 30, 2025
Summary
This study introduces a novel coordination polymer (CP-1) designed to deliver antimicrobial peptides (AMPs). CP-1 enhances AMP stability and facilitates bacterial membrane disruption, offering a new strategy against drug-resistant infections.
Area of Science:
- Coordination chemistry
- Materials science
- Antimicrobial drug delivery
Background:
- Antimicrobial peptides (AMPs) show promise against resistant bacteria but suffer from poor bioavailability and stability.
- Developing effective delivery systems is crucial for clinical AMP utility.
Purpose of the Study:
- To design and synthesize a novel coordination polymer (CP-1) as a potential delivery system for AMPs.
- To investigate the binding affinity and mechanism of action of an AMP-CP-1 complex against bacterial membranes.
Main Methods:
- Synthesis and characterization of the 2D coordination polymer {[Cu(dUMP)(dpp)2]·3(H2O)·(NO3)}n (CP-1) using techniques like X-ray diffraction and spectroscopy.
- Molecular docking and molecular dynamics simulations to assess AMP binding and membrane interaction.
- Chirality transfer analysis.
Main Results:
- A novel, enantiomerically pure 2D coordination polymer (CP-1) with a double helical structure was successfully synthesized.
- Molecular docking identified DGL 13K as the AMP with the highest binding affinity to CP-1.
- Molecular dynamics simulations revealed that the CP-1-DGL 13K complex disrupts Gram-negative bacterial membranes by promoting pore formation.
Conclusions:
- CP-1 shows potential as a carrier for AMPs, enhancing their stability and efficacy.
- The CP-1-AMP complex effectively disrupts bacterial membranes, offering a promising approach for novel antimicrobial therapies.
- This work provides a foundation for developing advanced drug delivery systems to combat antimicrobial resistance.

